Naperville, IL, United States of America

Soon Seog Jeong

This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents and 6 EPO patents. Top assignees: Apt Therapeutics, Inc., Humanzyme Limited, Monsanto Technology LLC. Active years: 2007-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soon Seog Jeong. Retrieved from https://idiyas.com/inventor/soon-seog-jeong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 46(Granted Patents)

Location History:

Maryland Heights, MO (US) (2007)
St. Louis, MO (US) (2007 - 2011)
Naperville, IL (US) (2012 - 2015)

Company Filing History:

5 out of 5

Apt Therapeutics, Inc.

Monsanto Technology LLC

where one patent can have more than one assignee

Years Active: 2007-2015

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9169309 - Thermostable variants of fibroblast growth factors (2015-10-27),

2. 8771683 - Therapeutic apyrase constructs, apyrase agents, and production methods (2014-07-08),

3. 8535662 - Apyrase therapy for bleeding conditions (2013-09-17),

4. 8236527 - Recombinant production of authentic human proteins using human cell expression systems (2012-08-07),

5. 8021866 - Therapeutic use of ADPase enhanced apyrases (2011-09-20),

6. 7390485 - Design and therapeutic use of adpase enhanced apyrases (2008-06-24),

7. 7247300 - Therapeutic use of soluble CD39L3 (2007-07-24),

8. 7217865 - Transgenic high tryptophan plants (2007-05-15),

Title: Innovations and Contributions of Soon Seog Jeong

Introduction

Soon Seog Jeong is a notable inventor based in Naperville, IL (US), recognized for his significant contributions to the field of biotechnology. With a total of 8 patents to his name, he has made remarkable advancements in the development of therapeutic proteins and their applications.

Latest Patents

Among his latest patents, Soon Seog Jeong has developed thermostable variants of fibroblast growth factors. This technology relates to engineered human Fibroblast Growth Factor-2 (FGF2) proteins, which exhibit increased thermostability compared to the wild-type protein. The methods and compositions he has created are particularly useful in the culturing of embryonic stem cells. Another significant invention is the therapeutic apyrase constructs, which provide a new class of enhanced apyrases (EN-apyrases). These EN-apyrases possess superior pharmacokinetic, pharmacodynamic, and pharmacochemical properties, and can be purified using simplified procedures. The invention also includes constructs for transforming a cell to produce these EN-apyrases, which comprise sequences encoding a signal sequence, a linker, and a soluble apyrase.

Career Highlights

Throughout his career, Soon Seog Jeong has worked with various companies, including Apt Therapeutics, Inc. and Humanzyme Limited. His work in these organizations has contributed to the advancement of biotechnological innovations and therapeutic solutions.

Collaborations

He has collaborated with notable individuals in the field, including Ridong Chen and Timothy A Mitsky. These collaborations have further enhanced the impact of his inventions and research.

Conclusion

Soon Seog Jeong's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications and protein engineering.

Profile summary based on public USPTO records.